Quercitrin (3-rhamnosylquercetin) is a bioflavonoid contained in sever
al crude drugs traditionally used for its antidiarrhoeal activity. The
antidiarrhoeic effect of quercitrin on experimental chronic diarrhoea
in rats was studied. Adult rats were fed for 14 days with a synthetic
diet in which all soluble carbohydrates were substituted by lactose,
resulting in chronic diarrhoea with body weight loss, colonic hyperpla
sia, reduced average cell size, increased alkaline phosphatase activit
y, increased mucus production and cytopathological alterations of the
enterocyte. The rest of the animals were allowed to recover from chron
ic diarrhoea for 3 or 7 days, by feeding them with a standard diet, an
d half of them were also given quercitrin orally (50 mg/kg day). Diarr
hoea ceased 48 h after lactose withdrawal, and body weight recovery wa
s apparent after 3 days. Nevertheless, most of the alterations of the
colonic mucosa persisted at that time. Quercitrin-treated rats had les
s diarrhoeal output and did not show mucosal hyperplasia after three d
ays of treatment. Ah animals had greatly recovered by the seventh day,
but histological alterations were still present, although to a lesser
extent in quercitrin-treated rats. Quercitrin and related flavonoids
may play a role in intestinal repair following chronic mucosal injury.